SMBC Nikko Downgrades Jounce Therapeutics to Neutral

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

byBenzinga Newsdesk

February 24, 2023

1 minute read

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

Oppenheimer Maintains Outperform on Costco Wholesale, Raises Price Target to $580

By Benzinga Newsdesk

Today, 9:33 AM

Oppenheimer analyst Rupesh Parikh maintains Costco Wholesale (NASDAQ:COST) with a Outperform and raises the price target from $550 to $580.

COST

Hill To Provide Construction Management Services For Marina Towers Project, Egypt

By Akanksha Bakshi

Today, 9:33 AM

City Edge Development on behalf of the New Urban Communities Authority (NUCA) has selected Hill International Inc (NYSE: HIL) to provide construction management services for its flagship mixed-use project in the New Alamein City, North Coast, Egypt. Financial terms were not disclosed.

HIL

Sapiens Intl Corp Q3 EPS $0.31 Beats $0.29 Estimate, Sales $118.40M Beat $117.94M Estimate

By Benzinga Newsdesk

Today, 9:33 AM

Sapiens Intl Corp (NASDAQ:SPNS) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.29 by 6.9 percent. This is a 14.81 percent increase over earnings of $0.27 per share from the

SPNS

Here’s Why Everbridge Shares Are Trading Higher Today

By Anusuya Lahiri

Today, 9:33 AM

Everbridge Inc (NASDAQ:EVBG) shareholder Ancora Holdings Group, LLC urged the board to explore strategic alternatives. Ancora acknowledged that multiple financial sponsors…

EVBG

SMBC Nikko Downgrades Jounce Therapeutics to Neutral

Related Posts

Oppenheimer Maintains Outperform on Costco Wholesale, Raises Price Target to $580

Hill To Provide Construction Management Services For Marina Towers Project, Egypt

Sapiens Intl Corp Q3 EPS $0.31 Beats $0.29 Estimate, Sales $118.40M Beat $117.94M Estimate

Here’s Why Everbridge Shares Are Trading Higher Today